Literature DB >> 7807929

SSIEM Award. Impaired metabolism of leukotrienes in inherited metabolic disorders.

E Mayatepek1, G F Hoffmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7807929     DOI： 10.1007/bf00711803

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Metabolism and analysis of endogenous cysteinyl leukotrienes.

Authors:  D Keppler; M Huber; W Hagmann; H A Ball; A Guhlmann; S Kästner
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Metabolism of cysteinyl leukotrienes in monkey and man.

Authors:  M Huber; J Müller; I Leier; G Jedlitschky; H A Ball; K P Moore; G W Taylor; R Williams; D Keppler
Journal:  Eur J Biochem       Date:  1990-11-26

4.  Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency.

Authors:  E Mayatepek; G F Hoffmann; H J Bremer
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

5.  Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.

Authors:  G Jedlitschky; M Huber; A Völkl; M Müller; I Leier; J Müller; W D Lehmann; H D Fahimi; D Keppler
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

6.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Clinical and biochemical phenotype in 11 patients with mevalonic aciduria.

Authors:  G F Hoffmann; C Charpentier; E Mayatepek; J Mancini; M Leichsenring; K M Gibson; P Divry; M Hrebicek; W Lehnert; K Sartor
Journal:  Pediatrics       Date:  1993-05       Impact factor: 7.124
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.